Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has received an average rating of “Hold” from the thirteen research firms that are covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $13.29.
A number of equities research analysts have recently commented on MDRX shares. Cantor Fitzgerald reiterated a “buy” rating and set a $25.00 price objective on shares of Menlo Therapeutics in a research report on Thursday, May 2nd. Zacks Investment Research downgraded GenMark Diagnostics from a “hold” rating to a “sell” rating in a research report on Wednesday, April 24th. BidaskClub upgraded Zai Lab from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 28th. Finally, ValuEngine downgraded Welbilt from a “hold” rating to a “sell” rating in a research report on Wednesday, June 12th.
Several large investors have recently made changes to their positions in the company. Magnus Financial Group LLC bought a new position in shares of Allscripts Healthcare Solutions during the fourth quarter valued at about $111,000. ETF Managers Group LLC boosted its position in shares of Allscripts Healthcare Solutions by 9.7% in the first quarter. ETF Managers Group LLC now owns 11,589 shares of the software maker’s stock valued at $111,000 after acquiring an additional 1,028 shares during the period. Connable Office Inc. bought a new stake in Allscripts Healthcare Solutions during the first quarter valued at approximately $114,000. QS Investors LLC lifted its position in Allscripts Healthcare Solutions by 5,105.5% during the fourth quarter. QS Investors LLC now owns 12,337 shares of the software maker’s stock valued at $119,000 after purchasing an additional 12,100 shares during the last quarter. Finally, Menta Capital LLC lifted its position in Allscripts Healthcare Solutions by 24.2% during the fourth quarter. Menta Capital LLC now owns 13,417 shares of the software maker’s stock valued at $129,000 after purchasing an additional 2,613 shares during the last quarter.
MDRX stock traded down $0.09 on Friday, reaching $11.53. The company’s stock had a trading volume of 982,780 shares, compared to its average volume of 1,524,057. Allscripts Healthcare Solutions has a 52 week low of $8.54 and a 52 week high of $14.97. The company has a market capitalization of $1.93 billion, a P/E ratio of 20.96, a P/E/G ratio of 2.40 and a beta of 1.31. The business has a fifty day simple moving average of $10.79. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.04 and a quick ratio of 1.04.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 2nd. The software maker reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. Allscripts Healthcare Solutions had a return on equity of 6.92% and a net margin of 20.60%. The business had revenue of $432.00 million during the quarter, compared to analyst estimates of $436.47 million. During the same period in the prior year, the company posted $0.16 EPS. The business’s revenue for the quarter was down .4% compared to the same quarter last year. Research analysts anticipate that Allscripts Healthcare Solutions will post 0.47 earnings per share for the current fiscal year.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Read More: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.